论文信息 - The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP–PKA–EGFR–STAT3 axis - 字舞流文

The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP–PKA–EGFR–STAT3 axis

A. Cheng | A. Chan | Hanyong Sun | M. Zhou | M. T. Mok | G. Xu | Yu Huang | H. Sun | Y. Huang | A. W. Chan